We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AURE3:BMFBOVESPAAuren Energia SA Analysis

Data as of 2026-03-17 - not real-time

R$11.88

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at 11.88 BRL, just below its calculated resistance of 12.27 BRL, while the 20‑day and 50‑day SMAs (11.78 BRL and 11.64 BRL) sit comfortably beneath the current price, confirming a short‑term bullish trend. Momentum indicators are mixed: the RSI of 52.8 suggests neutral pressure, and the MACD line (0.045) is marginally below its signal (0.046), hinting at a potential bearish crossover ahead. Volatility remains elevated at roughly 33 % over the past 30 days, but beta is low (0.25), indicating the stock moves less than the broader market.
Fundamentally, Auren Energia posted a 20 % revenue surge, yet profitability is weak with a negative net margin and a trailing EPS of –0.64 BRL. The company carries a heavy debt load (≈24.7 bn BRL) and a debt‑to‑equity ratio above 170 %, while cash reserves sit at 4.38 bn BRL. The DCF‑derived fair value of 9.48 BRL implies a modest upside of about 7 % relative to the current price, and the forward PE of 33.7 is above the industry average of 23.4, suggesting the stock is priced at a fair to slightly overvalued level. Dividend yield is low (0.48 %) with a zero payout ratio, raising questions about sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at 12.27 BRL
  • Bullish SMA alignment with current price
  • MACD approaching bearish crossover

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 20 % revenue growth and positive forward EPS
  • DCF upside of ~7 % and fair valuation
  • Increasing volume trend supporting liquidity

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High leverage and negative ROE
  • Low dividend yield with sustainability concerns
  • Stable utilities‑renewable sector offset by regulatory uncertainty

Key Metrics & Analysis

Financial Health

Revenue Growth20.10%
Profit Margin-5.04%
P/E Ratio33.7
ROE-3.95%
ROA2.57%
Debt/Equity179.20
P/B Ratio1.0
Op. Cash FlowR$1.4B
Free Cash FlowR$-55760500
Industry P/E23.4

Technical Analysis

TrendBullish
RSI52.8
SupportR$0.00
ResistanceR$12.27
MA 20R$11.78
MA 50R$11.64
MA 200R$10.88
MACDBearish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Fair ValueR$9.48
Target PriceR$12.77
Upside/Downside7.48%
GradeFair
TypeBlend
Dividend Yield0.48%

Risk Assessment

Beta0.25
Volatility32.91%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.